To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized (1:1), double-blind, placebo-controlled phase 2 study to assess safety
and efficacy of Total TQ Formula (3 g daily dose of Nigella Sativa Oil) capsules versus
placebo in treating patients who have tested positive for novel Coronavirus 2019 (Covid-19)
in the outpatient setting.
Patients will be treated at a dose of 500 mg, 3 capsules, two times a day for 14 days from
date of randomization. Quantitative viral load as measured by RT-PCR will be evaluated at
baseline and on days 7 and 14. Covid-19 symptoms will be measured throughout the study using
Modified FLU-PRO Plus.